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INTRODUCTION 
INTRODUCTION 
Myocardial Infarction is a serious complication of Atherosclerotic 
Coronary Heart Disease. Coronary Heart Disease was first described by 
William Herberden in 1768. In 1932 unipolar leads were discovered by Wilson 
and the establishment of coronary care units by Day and Brown has lead to the 
world wide proliferation of coronary care units. The current knowledge of 
pathophysiology of acute myocardial infarction started with the autopsy 
description of Dr. James Herrick from Chicago in 1912 who concluded that 
acute myocardial infarction results from thrombotic occlusion of coronary 
artery and prophesized that the hope of salvaging the muscle, lay in restoration 
of blood flow. 
Despite impressive strides in diagnosis and management over the last 
three decades, Acute Myocardial Infarction (AMI) continues to be a major 
public health problem even in the industrialized world. In the United States 
nearly 1.5 million patients annually suffer from AMI (about one patient every 
20 seconds).1 Myocardial Infarction2 is an acute cardiac disability arising from 
reduction or arrest of blood supply to the myocardium due to atherosclerotic or 
non-atherosclerotic lesions of coronary arteries. Virtually all acute infarcts are 
caused by thrombosis developing in a culprit vessel with ruptured 
atherosclerotic plaque. Usually coronary artery occlusion is associated with 
infarction of myocardium, though post-mortem examination of cases of sudden 
1 
deaths reveals evidence in only 20% of cases, the remaining 80% do not 
showing any change. 
Accurate diagnosis is mandatory because mistaken diagnosis can be disastrous 
to the social, economical and family life of the patient. At one end of the 
spectrum is the danger of missing a potentially lethal illness, on the other hand 
mistaken diagnosis results in severe cardiac neurosis which is even more 
difficult to treat than the original disease itself. 
The presenting symptoms may vary from severe pain in the chest to 
minimal symptoms, with the disease remaining unrecognized. In most patients 
there is a substernal heaviness3 which radiates to the left shoulder or ulnar 
surface of forearm and hand. It can also radiate to back, interscapular region, 
root of neck, jaw and teeth. In others it presents as breathlessness, syncope, 
giddiness, fatigue, abdominal pain, nausea, vomiting and unexplained 
hypotension. 
Coronary Heart Disease is more age dependant in women than in men. 
Women are usually 10 years older than men when any coronary manifestation 
first appears and Myocardial Infarction occurs as much as 20 years later 4. 
Coronary Heart Disease is the leading cause of death in women and the 
lifetime risk of death is 31% in postmenopausal women. The median age of 
menopause is 51.4 years5 and age distribution ranges from 40-58 years.  
2 
Data from Framingham study says that the incidence of cardiovascular 
disease is 3 times more in men than women (before menopause) and 
approximately equal in men and women aged 75-79 years. The incidence in 
women rises after menopause due to hormonal changes 
Overall mortality and morbidity in coronary heart disease depends on age, sex, 
site and extent of infarction, presence of good collateral circulation and 
associated co-morbid conditions. 
C-reactive protein is a hepatically derived marker of low grade systemic 
inflammation that largely reflects circulating cytokine formation. It is 
produced from liver in response to cytokine stimulation (interleukin 1 and 6) 
It is reasonable to suggest that high CRP levels are associated with 
adverse outcome as a result of coronary instability.6,7 CRP, at least, partially 
reflects the extent of myocardial necrosis and can be used to predict in-hospital 
and long-term outcome in patients with AMI.8-14 Several large-scale 
prospective studies have shown the inflammatory marker - high sensitivity 
CRP (hs-CRP) to be a potent predictor of future MI, stroke and peripheral 
vascular occlusion among apparently healthy men and women, as well as 
among high-risk smokers15 and the elderly.16 
   
Systemic proinflammatory mediators, particularly hs-CRP and leukocytes were 
higher in AMI patients. High CRP levels in the acute phase strongly indicate 
3 
poor early clinical outcome of the patients with AMI.17 In AMI, the peak plasma 
value of CRP can also be used to predict the risk of cardiac rupture18 as well as 
short19, 20 and long-term21-23 prognosis. Estimation of CRP levels in acute phase 
may provide valuable information on left ventricular (LV) function and exercise 
capacity and can help in long-term risk stratification after AMI. 
 Despite successful early recanalization of an occluded infarct artery by 
percutaneous coronary intervention (PCI) or thrombolysis, up to one-third of 
AMI patients still fail to obtain complete myocardial reperfusion due to a 
process of myocardial reperfusion injury24, 25. This phenomenon is characterised 
by impairment of microcirculatory flow and by ongoing ischemia and tissue 
necrosis 26, 27. Although the underlying mechanisms of reperfusion injury are 
still not fully elucidated, there is accumulating evidence that local inflammatory 
responses with infiltration of leucocytes in the capillary circulation and release 
of oxygen-free radicals play a key role in this reperfusion-related tissue injury28, 
29. 
Reperfusion injury is characterised by impairment of microcirculatory 
flow and by ongoing ischemia and tissue necrosis. Evidence has accumulated 
that progressive capillary plugging by leukocytes causing capillary no-reflow 
and superoxide radical formation plays a role in this reperfusion injury. 
Recruitment of neutrophils is regulated through a complex sequence of 
molecular steps involving the selectins and integrins, which mediate leukocyte 
rolling and adhesion to the endothelium 6, 12. There is experimental evidence that 
4 
cytokines such as IL-1 and TNF-α are involved in this early stage of neutrophil 
infiltration by induction of endothelial adhesion molecules30. 
Myocardial reperfusion injury is defined as the presence of persistent 
ST-segment elevation despite successful coronary intervention (≥ 50% of the 
initial value). 
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AIM OF THE 
STUDY 
  
AIM OF THE STUDY 
 
1. To analyze high sensitive C-Reactive protein in Myocardial Infarction 
for 
   (a) Prediction of LV function 
   (b) Myocardial reperfusion injury 
   (c) Risk Prognostication following acute myocardial 
infarction 
2. To study the risk factors, common site of myocardial infarction in 
admissions to Coimbatore Medical College Hospital, and its complications. 
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REVIEW OF 
LITERATURE 
REVIEW OF LITERATURE 
 
A. ANATOMY OF CORONARY CIRCULATION (Fig 1) 
 
         The epicardial coronary arteries take origin from the right and left 
coronary sinuses. In 85% of patient the right coronary artery which gives rise 
to posterior descending artery supplies the entire right ventricle and large a 
part of the posterior wall of the left ventricle. This is referred to as right 
dominant circulation. 
 In 8% of patients the left coronary artery supplies entire left ventricle, 
interventricular septum and a portion of right ventricle. This is referred to as 
left dominant circulation. 
In 7% of patients referred to as co-dominant circulation, the right coronary 
artery supplies right ventricle and posterior wall of interventricular  septum 
while left coronary supplies the left ventricle and anterior portion of 
interventricular septum. 
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Fig 1. Diagram of Myocardium (1) of a branch of the leftcoronary artery (2) of the tip of the anterior 
wall of the heart (LCA, right coronary artery = RCA). 
 
Fig 2. Fatty‐streak formation in atherosclerosis 
 
 
 
 
B.AETIOPATHOGENESIS OF MYOCARDIAL INFARCTION 
1. ATHEROSCLEROSIS31, 32 
Atherosclerosis is characterized by formation of atheroma or fibro 
fatty plaque which consists of a raised focal plaque within the intima, 
having a core of lipid and a covering of fibrous cap. (Fig 2, 3, 4, 5) 
Atherosclerosis33, 34 is the single most important etiological factor 
for coronary heart disease. The search for the cause and pathogenesis of 
atherosclerosis has become an insistent “golden grail”. The acceptable 
hypotheses are 
A) LIPID INSUDATION OR INFILTRATION HYPOTHESIS: 
This is the modified “imbibition hypothesis”35 termed by Virchow 
in 1856 which stated that cellular proliferation in intima was a form of 
low grade inflammation as a reaction to increased infiltration of plasma 
protein and lipids from the blood. 
B)  ENCRUSTATION OR THROMBOGENIC HYPOTHESIS: 
This theory ascribed to Rokitansky, postulated that small thrombi 
composed of platelet, fibrin and leukocytes collected over foci of 
endothelial injury organized and their gradual growth resulted in plaque 
formation. 
 
 
8 
Fig 3. Illustration of the traditional concept of microcirculatory impairment in the setting of no flow in the 
proximal LAD compared with preserved flow in the left circumflex coronary artery, as typically seen in acute 
anterior ST‐segment elevation myocardial infarction (upper left panel). The sequence starts with the 
vulnerable atherosclerotic plaque, which, by rupture or fissure, causes thrombus formation and thereby 
complete coronary artery occlusion. Embolization of particulate matter, potentially aggravated by PCI, in 
addition to ischaemia, oxidative stress, and inflammation can lead to dysfunction of the myocardial 
microcirculation with impairment of myocardial perfusion that can persist or be even intensified after 
restoration of epicardial blood flow. 
 
Fig 4. The non‐traditional concept centres on the vulnerable patient, taking into account primary 
dysfunction of the microcirculation of a vulnerable myocardium in addition to the vulnerable 
plaque, which contributes to the clinical presentation and outcome. 
 
 
C)  REACTION TO INJURY HYPOTHESIS: 
This widely accepted theory formulated by Ross and Glomset in 
1976 and modified in 1986 states that the lesions of atherosclerosis are 
initiated as a response to some form of injury to arterial endothelium. 
Endothelial injury leads to attachment of monocytes and platelets, 
proliferation of smooth muscle cells in the arterial intima and deposition 
of intracellular and extracellular lipids. 
2. NON-ATHEROSCLEROSIS 36 
 Non-atherosclerotic causes of Myocardial Infarction are 
1) Congenital anomalies like single coronary artery, atresia of 
coronary ostium, myocardial bridges, coronary AV fistula etc. 
2)  Dissection of coronary artery or aorta. 
3)  Embolic phenomena from prosthetic valves, infective 
endocarditis, tumors, calcium, paradoxical embolus, etc. 
4) Traumatic injury or spasm of coronary artery. 
5) Coronary arteritis due to Takayasu Disease, Polyarteritis Nodosa, 
SLE, Syphilis, Kawasaki Disease 
6) Metabolic disorders like Mucopolysaccharidoses, Homocystinuria, 
Fabry’s Disease and Amyloidosis. 
7) Substance abuse like cocaine, amphetamine. 
9 
8) Myocardial oxygen demand-supply disproportion due to aortic 
stenosis, systemic hypotension, carbon monoxide poisoning, 
thyrotoxicosis. 
9) Intimal proliferation due to irradiation, cardiac transplantation, 
fibro muscular hyperplasia. 
10) Miscellaneous cause like HOCM, hypercoagulable states, 
diabetes mellitus.  
3.  RISK FACTORS FOR MYOCARDIAL INFARCTION 37, 38, 39 
(TABLE 1) 
 
 The term risk is widely used to describe those characteristically 
found in healthy individuals that relate to the subsequent appearance 
of Ischaemic Heart Disease37. The risk of Ischaemic Heart Disease is 
determined by the aggregation of individual factors. 
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Table 1: RISK FACTORS FOR CORONARY HEART DISEASE 
 
 
A. FIXED 
1. Age 
2. Male sex 
3. Family History 
B. MODIFIABLE 
1. Smoking 
2. Hypertension 
3. Lipid Disorders 
4. Diabetes Mellitus 
5.Haemostatic variables 
6. Sedentary Life Style 
7. Obesity 
8. Mental Stress 
9. Personality 
10. Oral Contraceptive Pills 
11. Hyperhomocysteinemia 
12. Inflammation 
11 
1. AGE: 
Age  is a definite unmodifiable risk factor. Atherosclerosis develops 
progressively as age advances. Atherosclerosis is rarely present in early 
childhood, except in familial hyperlipidemia, but it is often detectable in 
postmortem specimens of young age between 15-30 years. Atherosclerosis is 
universal in elderly. 
2. SEX: 
 Men are more affected than premenopausal women. However after 
menopause the incidence of atheroma rises in women. This suggests that 
oestrogen probably plays a part in preventing or delaying atherosclerosis. 
There is also a fall in HDL levels in postmenopausal women which may also 
contribute. 
3. FAMILY HISTORY: 
 Coronary artery disease runs in families. This may be due to genetic 
factors or the effects of a shared environment (similar diet, smoking habits 
etc,). A positive family history is generally accepted to refer to those patients 
in whom a first degree relative of the patient has developed Ischaemic Heart 
Disease before the age of 50 years40. 
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4. SMOKING: 
 Tobacco is probably the most important avoidable cause of coronary 
disease. The incidence of Ischaemic Heart Disease is 3-5 times higher in 
smokers who smoke 20 cigarettes per day compared to non-smokers. There is 
a strong, consistent and dose linked relationship between cigarette smoking 
and Ischaemic heart disease. The incidence of sudden death is also higher in 
smokers. Smoking decreases HDL cholesterol levels. It accelerates 
atherosclerosis, plaque instability, increases the risk of thrombosis, myocardial 
infarction and death.  
Continuation of smoking increases incidence of restenosis after 
Percutaneous Transluminal Coronary Angioplasty and Coronary Artery 
Bypass Grafting. The relative risk is highest in young people and becomes 
significantly lower within 6 months of quitting. 
5. HYPERTENSION:  
 The incidence of coronary heart disease increases as blood pressure rises 
and the excess risk is related to both systolic and diastolic blood pressure. In 
the Framingham study, the incidence of Coronary Artery Disease in middle 
aged persons with blood pressure exceeding 160/95mmHg was 5 times more 
than that in normotensive men.  For each 10mmHg increase in Diastolic Blood 
Pressure there is 37% increase in risk of Coronary Heart Disease41. 
13 
Antihypertensive drugs have shown to reduce coronary mortality particularly 
by interruption of renin angiotensin system. 
6. LIPID DISORDERS: 
 A diet rich in saturated fat and cholesterol is associated with increased 
incidence of atherosclerosis. There also appears to be a genetic variation in the 
ability of dietary cholesterol to influence plasma cholesterol and 
atherosclerosis. 
 A wealth of evidence from epidemiological, clinical and experimental 
studies has established the association between hyperlipidemia and 
atherosclerosis. Hypercholesterolemia is clearly a risk factor. 
Of the lipoprotein, it is the low density lipoprotein (LDL) which is most 
atherogenic. VLDL is comparatively less atherogenic. HDL offers a protective 
effect and helps in removing cholesterol from the arterial wall. The ratio of 
LDL/HDL is a common way to assess atherogenicity of hyperlipidemia. A 
ratio of more than 4.5 is supposed to be atherogenic. A minor increase of 
1mg/dl in HDL-4 Cholesterol produces a 2-4% decrease in the risk of 
developing Acute Myocardial Infarction. 
The LDL cholesterol profiles are categorized as phenotypic pattern A, B 
and C. Patients with pattern B have mostly small, dense LDL particles. Small, 
dense LDL particles have been causally linked to an increased risk of coronary 
artery disease independent of total LDL cholesterol levels. The phenotype B 
14 
pattern is often, but not always associated with elevated triglycerides and 
triglyceride rich lipoproteins, reduced HDL and other features of insulin 
resistance syndrome. It has been suggested that small dense LDL particles are 
more atherogenic because of greater retention in the arterial wall and increased 
susceptibility to oxidation. 
There is increasing evidence that hypertriglyceridemia is independently 
linked with coronary atheroma even after adjustment for HDL levels. In 
Indians living in India or abroad, raised triglycerides with low HDL has been 
found to be atherogenic.   
.  7. DIABETES MELLITUS: 
 Diabetes Mellitus42 is a coronary heart disease risk equivalent. The 
abnormal lipid profile with insulin resistance known as Diabetic Dyslipidemia 
(small dense LDL, low HDL, elevated triglyceride) account for part of 
elevated cardiovascular risk. Diabetes increases the frequency of 
atherosclerosis. It is likely that post prandial hyperglycemia may be more 
important in the development of coronary artery disease than fasting 
hyperglycemia.  Diabetic women are 5-6 times more prone for coronary heart 
disease43compared to men. 
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8. HAEMOSTATIC FACTORS 
 High levels of fibrinogen and factor 7 are associated with increased risk 
of myocardial infarction. Polymorphism of factor 7 gene may increase the risk 
of Myocardial Infarction26. The stability of an arterial thrombus depends on the 
balance between fibrinolytic factors like plasmin and inhibitors of the 
fibrinolytic system such as Plasminogen Activator Inhibitor (PAI) 1. However, 
the levels of tissue plasminogen activator and PAI-1 in plasma have not proven 
to add information beyond the lipid profile for assessment of cardiovascular 
risk. 
Apolipoprotein (a) has structural homology with plasminogen with 
which it is able to compete for cell surface binding. By displacing 
plasminogen, apolipoprotein (a) is able to inhibit cell surface mediated 
endogenous fibrinolysis by reducing the formation of Plasminogen Activator 
from Plasminogen. Plasma level of Lp (a) is largely genetically determined. Lp 
(a) levels do not potently predict risk in the population at large. 
9. SEDENTARY LIFE STYLE: 
 The recent National Institute of Health Consensus Panel on Physical 
Activity and Cardiovascular Health established a goal of atleast 30 min of 
moderate intensity physical activity on a daily basis. Exercise increases HDL 
cholesterol, lowers blood pressure, reduces blood clotting and promote 
collateral vessel development. 
16 
10. OBESITY: 
 Obesity44, particularly the male pattern of centripetal or visceral fat 
accumulation is probably an independent risk factor although it can be 
associated with hypertension, diabetes mellitus and physical inactivity. 
11. MENTAL STRESS AND PERSONALITY: 
 Stress is associated with increased catecholamine levels and high blood 
pressure thereby increasing the risk of coronary heart disease. 
Type A individuals who are ambitious, aggressive, impatient, competitive, 
always in a hurry and often frustrated are more prone to Ischaemic heart 
disease. 
12. ORAL CONTRACEPTIVE PILLS: 
 Oral contraceptives disturb the clotting mechanism through an increased 
inactivity of factor 7 and 10. It also increases platelet sensitivity to ADP and 
hence to platelet adhesiveness. Oestrogen retards atherosclerosis but 
accelerates thrombogenesis resulting in myocardial infarction in the rare 
susceptible person. 
 
13. HYPERHOMOCYSTEINEMIA: 
 A large body of literature suggests a relationship between 
hyperhomocysteinemia and coronary events. Several mutations in the enzymes 
17 
involved in homocysteine accumulation correlate with thrombosis and in some 
studies, coronary risk. Measurement of homocysteine levels should be 
reserved for individuals with atherosclerosis at a young age or out of 
proportion to established risk factors. 
14. INFLAMMATION (Fig 5, 6): 
 An accumulation of clinical evidence shows that markers of 
inflammation correlate with coronary risk. Inflammatory cells in the plaque 
may contribute to plaque destabilization by producing matrix degrading 
metalloproteinases and by inducing smooth muscle cell apoptosis. 
Inflammatory cells also contribute to plaque thrombogenicity by releasing 
tissue factor- a procoagulant protein that activates the clotting cascade 
resulting in thrombin generation which leads to platelet aggregation and fibrin 
deposition. Inflammation in atherosclerotic plaque may be incited by a number 
of factors, which include oxidized LDL, cigarette smoking and possibly 
infectious agents. Variation of plasma levels of CRP can prospectively predict 
risk of myocardial infarction. CRP levels also correlate with outcome of 
patients with acute coronary syndrome. Elevated levels of the acute phase  
 
18 
          
     Nonischemic left ventricular myocardium                                Reversible ischemic injury 
                           
   Early irreversible ischemic injury                      Acute myocardial infarct after 24 hours of ischemia 
            
Effect of reperfusion after reversible ischemic injury     Identification of myocardial infarct with dehydrogenase 
staining 
Fig5.Atherosclerosis‐ Histopathology
 CORONARY ANGIOGRAM SHOWING BLOCK IN PROXIMAL RIGHT CORONARY ARTERY AND ITS 
REAPPEARANCE AFTER THROMBOLYTIC THERAPY 
 
CORONARY ANGIOGRAM AND SCHEMATIC DIAGRAM SHOWING BLOCK IN LEFT ANTERIOR 
DESCENDING ARTERY 
 
Fig 6. A myocardial infarction occurs when an atherosclerotic plaque slowly builds up in the inner lining of a coronary 
artery and then suddenly ruptures, totally occluding the artery and preventing blood flow downstream. 
 
reactant CRP may merely reflect ongoing inflammation rather than a direct 
etiologic role of CRP in the coronary artery disease. 
Systemic inflammatory state is evaluated in the acute phase by 
measuring proinflammatory mediators hs-CRP .C-reactive protein (CRP) has 
been well recognized as a strong independent predictor of short-term and long-
term mortality after non–ST-segment elevation acute coronary syndromes. 
 One source of inflammatory stimulus could arise from infectious agents. 
Interest has resurged in the possibility that infections may cause or contribute 
to atherosclerosis. Recent evidences support the role of Chlamydia 
pneumoniae, Cytomegalovirus, Herpes virus, H.pylori or other infectious 
agents in atherosclerosis and restenosis following coronary intervention. 
Chronic bronchitis and chronic gingivitis (most often due to infection with 
Porphyromonus gingivalis) have also been linked to atherosclerotic vascular 
disease. These have been linked to Acute Coronary events based on 
seroepidemiologic data or identification of the organism in the atherosclerotic 
plaque. 
D. CLINICAL FEATURES (Fig 7) 
 Retrosternal chest discomfort is the cardinal symptom of myocardial 
infarction, but breathlessness, vomiting, giddiness, syncope are common 
features. Patient is anxious and experiences the fear of impending death. 
Syncope is usually due to arrhythmia or profound hypotension. Vomiting and  
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Fig 7. Rough diagram of pain zones in myocardial infarction (dark red = most typical area, light red = 
other possible areas, view of the chest). 
 
                                                     
 
Fig 8: Chest X‐ Ray showing Pericardial effusion 
 
 
 
 sinus bradycardia are often due to vagal stimulation and are particularly 
common in patients with inferior wall myocardial infarction. Many deaths 
occur within the first hour. Development of cardiac failure reflects the extent 
of myocardial damage and is the major cause of death in those who survive the 
first few hours of infarction. On examination signs of sympathetic activity like 
sweating, tachycardia may be present. Vomiting and bradycardia may also be 
present. Signs of impaired myocardial function like hypotension, oliguria, cold 
peripheries, raised JVP, muffled heart sounds, S3, basal crepitations, 
pansystolic murmurs may also be present. Pericardial rub may be present. 
E.INVESTIGATIONS 
1. LABORATORY FINDINGS: 
  Myoglobin levels are the earliest to rise. Creatine Kinase starts to 
rise at 4 hours, peaks at about 12 hours falls to normal levels within 48-72 
hours 45. The most sensitive markers of myocardial cell damage are the 
Cardiac Troponins T and I which are released within 4-6 hours and remain 
elevated for upto 2 weeks. Myoglobin levels peak at 6 hours and returns to 
normal at 24 hours. Aspartate transaminase starts to rise about 12 hours after 
infarction and reaches peak on the first or second day returning to normal 
within 3 or 4 days. Lactate dehydrogenase peaks at 3-4 days remains elevated 
for upto 10 days. 
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 Lipid profile (cholesterol – total, LDL & triglycerides) may be raised. 
Leukocytosis is usual, reaching a peak on the first day. The ESR becomes 
raised.  
2. CHEST RADIOGRAPHY (Fig 8): 
 Chest X-ray is important since it may show the consequences of 
ischaemic heart disease i.e. cardiac enlargement, ventricular aneurysm, signs 
of heart failure and pericardial effusion. These signs can support the diagnosis 
of ischaemic heart disease and are important in assessing the degree of cardiac 
damage. 
3. ELECTROCARDIOGRAPHY(FIG 9): 
 The ECG is usually a sensitive and specific way of confirming the 
diagnosis; however it may be difficult to interpret if there is bundle branch 
block or evidence of previous myocardial infarction. Occasionally the initial 
ECG is normal and the diagnostic changes appear a few hours later. The 
earliest ECG change is tall and widened T waves followed by ST elevation. 
Later on there is diminution in the size of R wave and in full thickness 
infarction a Q wave begins to develop. Subsequently T wave becomes 
inverted. 
21 
  
 
 
 
Fig 9. Electrocardiogram showing Acute Lateral wall Myocardial Infarction. 
 
 When there has been anteroseptal infarction abnormalities are found in 
one or more leads from V1 to V4, while Anterolateral Infarction produces 
abnormalities in V4-V6, aVL and in lead I. Inferior Wall Infarction is best 
shown in lead II, III and aVF, while at the same time leads I, aVL and the 
anterior chest leads may show reciprocal changes of ST depression. Infarction 
of the posterior wall of the left ventricle is not recorded in the standard leads 
by ST elevation or Q waves, but the reciprocal changes of ST depression and a 
tall R wave may be seen in leads V1-V3. Right ventricular infarction should be 
strongly suspected if, in the clinical setting of acute inferior wall myocardial 
infarction, there is ST elevation of 1mm or more in lead V1, V4R or any of the 
extra right precordial leads V4R-V6R. 
4. ECHOCARDIOGRAPHY (Fig 10): 
 Two dimensional echocardiography can be done to assess the cardiac 
chamber size, regional wall motion abnormalities, left ventricular hypertrophy, 
valve leaflet thickness and mobility, valve calcification, appearance of 
subvalvular and supravalvular structures, pericardial effusion, intracardiac 
masses and great vessels. 
  Doppler echocardiography is done to assess valve regurgitation, valve 
stenosis, valve area, valve gradients, intracardiac pressures, intracardiac shunts 
and ventricular diastolic filling. 
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 Transesophageal echocardiography is used to assess aortic disease, 
infective endocarditis, to find out source of embolism, abnormalities of mitral 
prostheses etc.  
 Stress echocardiography is done to find out new regional wall motion 
abnormalities, declining ejection fraction and increase in end systolic volume 
which are indicators of myocardial ischemia. 
5. RADIONUCLIDE SCANNING: 
 A radionuclide ventriculogram can be used to assess left ventricular 
function. Infarct ‘avid’ scanning is possible because some isotopes (e.g. 
Technetium) are taken up by freshly infarcted myocardium. This may help to 
establish the diagnosis in some patients who present after a cardiac arrest when 
it is sometimes difficult to interpret any ECG and enzyme changes. 
F. COMPLICATIONS OF MYOCARDIAL INFARCTION 37 
1. ARRHYTHMIAS: 
A. TACHYARRYTHMIAS: 
a. Premature ventricular complexes: 
 The commonest arrhythmia is premature ventricular complexes. This 
can be suppressed with IV lignocaine 100mg given as bolus. To prevent 
recurrence lignocaine infusion of 500-1000mg in 500ml of 5% dextrose is 
administered at a rate of 1-2mg/min. premature ventricular complexes can be 
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forerunners of life threatening ventricular tachycardia or ventricular 
fibrillation. 
b. Ventricular Tachycardia: 
 It needs immediate attention and should be treated by IV lignocaine. In 
case the drug is ineffective, DC shock of 150-200 joules will be effective in 
majority of the cases. Repeated attacks of ventricular tachycardia can be 
prevented by IV infusion of lignocaine, amiodarone or mexilitene. Ventricular 
pacing may also be effective. 
c. Ventricular Fibrillation:  
 The patient is pulseless and will have features of cardiac arrest. 
Immediate thump on the chest and an external cardiac massage is required. 
Defibrillation should be one by DC shock of 200-400 joules. Patients with 
repeated episodes may benefit from intravenous bretylium, amiodarone, 
mexilitene or lignocaine. 
d. Supraventricular Arrhythmias: 
 Atrial premature beats do not need specific treatment. However 
supraventricular arrhythmia, atrial flutter and atrial fibrillation require 
treatment with digoxin or verapamil. 
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e. Accelerated Ventricular or Junctional Rhythm: 
 Normally pace maker cells in the AV junctional and ventricular 
myocardium have a rate of 40-60/min. however in the settings of myocardial 
infarction, especially in acute inferior wall myocardial infarction, the rate of 
these pacemakers increases to about 80-120/min. Such a rhythm does not 
require specific treatment and is normally self limiting. If hemodynamic 
compromise occurs IV atropine (1.2mg) suppresses it by increasing the sinus 
rate. 
B. BRADYARRHYTHMIAS AND CONDUCTION DISTURBANCES: 
a. Sinus Node Dysfunction: 
 It may present as sinus bradycardia, sinus arrest or sinoatrial block 
usually due to vagal stimulation or in the settings of inferior wall infarction 
due to sinus node ischaemia. Symptoms of profound hypotension and shock 
may occur and occasionally asystole and cardiac arrest. Immediate treatment 
consists of IV atropine (1.2mg). If atropine is ineffective or this problem is 
persistent or recurring temporary pace making is necessary. 
b. AV Nodal Block: 
 It usually occurs with inferior wall myocardial infarction as first degree 
AV block, Wenkebach’s block or complete AV block. These blocks are 
usually transient and respond to IV atropine. If giddiness, hypotension or 
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other evidence of hemodynamic compromise occurs or if the ventricular rate 
is less than 50/min temporary pacing may be required. 
c. Distal Conduction Disturbances: 
 The distal conduction system consists of the right bundle and the 
anterior and posterior fascicles of the left bundle. Since the major blood 
supply to this part of the conduction system comes from the left coronary 
artery, conduction defects in the bundle branches are common in anterior wall 
infarction. Block of one of the fascicles of the left bundle does not have an 
ominous prognosis. However acute right or left bundle branch block or 
bifascicular block carries an ominous prognosis. Block in the three fascicles 
results in complete heart block with an unstable ventricular escape rhythm at a 
rate of 20-40 beats per minute. Clinical manifestations consists of syncopal 
attacks, hypotension and may lead to cardiac arrest. Temporary pacemaker 
insertion is necessary. Temporary pacing is also indicated in patients who 
develop bifascicular blocks since this can be a precursor of trifascicular block. 
Patients with bifascicular block who develop trifascicular block may need 
permanent pacemaker implantation. 
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2. ISCHAEMIA: 
 Post infarction angina occurs in upto 50% of patients. This is due to 
residual stenosis in infarct related vessel despite successful thrombolysis. 
3. ACUTE CIRCULATORY FAILURE: 
 Hemodynamic evidence of left ventricular dysfunction appears when 
contraction is seriously impaired in 20-25% of the left ventricle. Infarction of 
more than 40% of left ventricle results in Cardiogenic Shock which carries a 
bad prognosis. 
4. PERICARDITIS: 
 This may occur at any stage but is particularly common on the second 
and third day. The patient may recognize a different pain that is positional and 
worsens on inspiration. Dressler’s Syndrome may occur between 2 weeks and 
3 months after acute myocardial infarction 46 and has an autoimmune basis 
often accompanied by pleural and pericardial effusions, fever and raised ESR. 
Treatment requires the use of steroids. 
5. MECHANICAL COMPLICATIONS: 
a. Mitral regurgitation: 
 It is due to ischaemia or rupture of papillary muscle and is recognized 
by the presence of systolic murmur at the apex. If trivial, it is of no 
hemodynamic significance. However severe mitral regurgitation can induce 
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life threatening left ventricular failure and cardiogenic shock and may warrant 
urgent coronary angiography followed by coronary bypass surgery and mitral 
valve replacement. 
b. Ventricular septal defect: 
 It is a defect due to rupture of infarcted interventricular septum and is 
recognized by the presence of pansystolic murmur at the left sternal border. 
Diagnosis is possible by Echo-Doppler studies. It produces severe left heart 
failure and needs immediate surgical intervention. 
c. Cardiac Rupture: 
 It is a serious complication which results in cardiogenic shock and 
almost 100% mortality. Emergency treatment by pericardial tapping may 
prove life saving. Rare cases have been saved by emergency surgery. 
6. OTHER COMPLICATIONS: 
a. Left Ventricular Aneurysm: 
 The infarcted segments are dilated and show paradoxical movement and 
compromised left ventricular hemodynamics. It is recognized by persistent ST 
elevation in ECG and dyskinesia seen in echocardiography and radionuclide or 
contrast ventriculography. It may result in persistent left ventricular failure, 
arrhythmias and systemic embolism. Treatment consists of aneurysmectomy 
and associated coronary artery bypass surgery if so indicated. 
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b. Thromboembolism:  
 Formation of a thrombus within the left ventricle followed by systemic 
arterial embolism leading to occlusion of a peripheral artery requires 
immediate surgical embolectomy in accessible vessels. Pulmonary embolism 
originates in the leg veins due to prolonged immobilization. These are 
prevented by anticoagulation. Massive embolism may result in shock and 
sudden death. Thrombolytic therapy and embolectomy are occasionally 
required. The condition can be prevented by low molecular weight heparin. 
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MATERIALS AND 
METHODS 
 
MATERIAL AND METHODS 
 
During the period from 1st Jan 2007 to 30th Jun 2007 100 patients admitted 
with acute myocardial infarction in coronary care unit, CMC Hospital, 
Coimbatore, with a window period of less than 12 hrs were analysed. 
 In the present study, the WHO criterion 4 was followed to diagnose 
myocardial infarction. Among the following criteria atleast two of the three 
had to be present for accepting the case as myocardial infarction (Fig 11). 
1) Typical history of retrosternal chest pain. 
2) Serial ECG changes 47, 48, 49: Appearance of pathological Q wave or 
appearance of ST elevation with T wave inversion in atleast 2 or more leads, 
new onset left bundle branch block (LBBB).. 
3) Raised CPK-MB taken 12-24 hours after the onset of symptoms. 
After careful history taking, physical signs were recorded in detail. 
History of prolonged hypertension, diabetes were taken into consideration. 
History of oral contraceptive intake, cigarette smoking were noted.
 Menstrual history was recorded for females. Serum analysis of High 
sensitive C-reactive protein, WBC count was taken before thrombolysis. 
Cholesterol and blood sugar were done. Electrocardiography was taken in all  
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 Fig 10. ECHO SHOWING ACUTE MITRAL REGURGITATION 
 
 Fig 11. Schema for diagnosis of Myocardial Infarction 
 
cases at the time of admission and Echocardiography was done on day 
3.Window Period were also recorded. 
Serum cholesterol was considered to be increased if it was greater than 
200mgm%. Waist circumference more than 94cms for males and 80cms for 
females was taken as obese. BMI were also recorded. The type and extent of 
infarction were judged by the Q wave and ST elevation in serial ECGs. 
Myocardial reperfusion injury was defined as the presence of persistent 
ST-segment elevation despite successful coronary intervention (≥ 50% of the 
initial value). 
Despite successful early recanalization of an occluded artery by 
thrombolysis, up to one-third of AMI patients still fail to obtain complete 
myocardial reperfusion due to a process of myocardial reperfusion injury50, 51. 
This phenomenon is characterised by an impairment of microcirculatory flow 
and by ongoing ischemia and tissue necrosis52, 53. 
Although the underlying mechanisms of reperfusion injury are still not 
fully elucidated, there is accumulating evidence that local inflammatory 
responses with infiltration of leucocytes in the capillary circulation and release 
of oxygen-free radicals play a key role in this reperfusion-related tissue 
injury54, 55. However, the occurrence and the extent of reperfusion injury is 
variable and is not solely related to the severity and duration of myocardial 
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ischemia51, 56. Whether the pre-existing systemic inflammatory state might be 
another important determinant of this phenomenon is unknown. 
ST-segment elevations of less than 50% (ST < 50%) indicated good 
myocardial reperfusion without significant ongoing tissue injury. There is a 
good reproducibility of these measurements in previous reports57. 
Once diagnosis was established routine management was carried out which 
included bed rest, oxygen therapy, sedation with narcotics, coronary 
vasodilator, thrombolytic and antiplatelet treatment. Blood pressure and pulse 
were recorded and continuous ECG monitoring was done for the first 48 hours 
along with ½ hourly pulse, blood pressure, temperature and respiration 
recording. 
 A careful observation was made on all patients for the development of 
arrhythmias, left ventricular failure, cardiogenic shock and other 
complications. They were treated accordingly. 
 A detailed record of the illness was maintained. 
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Cardiovascular Risk Classification 
The AHA and CDC defined three risk groups as follows (TABLE 2): 
Risk Level CRP (mg/L) CRP (mg/dL) 
Low <1.0 <0.10 
Average 1.0 - 3.0 0.10 – 0.30 
High >3.0 >0.30 
TABLE 2 
Levels of hs-CRP are also elevated among those with acute coronary 
syndromes at high risk for recurrent events and among post-MI patients at high 
risk for recurrent instability. These effects are independent of other risk factors 
and appear to add to the predictive value of lipid screening in terms of risk 
prediction. 
Plasma C-reactive protein was measured at the time of admission by 
immunonephalometry method. The normal value of the C-reactive protein is 
taken as 0.08 mg/L. Electrocardiography is done at the time of admission and 
after 1 hr of thrombolysis. Echocardiographic study is done on day three of 
admission and ejection fraction is estimated by modified Simpson’s method. 
Patients are classified into three groups based on level of C-reactive protein: 
those with low C-reactive protein level (<1 mg/L), intermediate (1-3 mg/L) 
and those with high C-reactive protein level (>3 mg/L). 
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Two ml of blood is taken before thrombolysis and plasma CRP level 
was estimated by immunonephalometry method by auto analyzer. Normal 
value of CRP is < 0.8 mg/dl. Patients should not have other conditions known 
to modify the plasma CRP level i.e. collagen vascular disease, advanced liver 
disease, malignancy, septicemia, other inflammatory infectious diseases. i.e. 
chronic obstructive pulmonary disease/bronchitis, pulmonary tuberculosis and 
arthritis, as these conditions are known to modify CRP levels. 
All patients with AMI are thrombolysed with 1.5 million units of 
streptokinase.  Aspirin, isosorbide dinitrate, beta blocker etc. are used in routine 
manner. Echocardiography is done in all patients on day three; the LV volume 
and EF are evaluated by modified Simpson’s method. Doppler diastolic indices 
are also calculated.  
Methodology: Latex immunonephalometry   
Specimen: Serum or plasma 
Volume:    1 mL 
Minimum Volume:  0.5 mL 
Container:  Red-stopper tube  
Collection: Separate serum or plasma from cells within 1 hour after collection. 
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Storage Instructions: Refrigerate (maximum 8 days). May be frozen at -25°C 
or lower if samples are frozen within 24 hours after collection. Repeated freeze-
thaw cycles are to be avoided. 
Causes for Rejection:  Gross lipemia in tissue injury, infections or 
inflammation, which may cause elevated CRP levels, should also be considered 
when interpreting results. 
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OBSERVATION  
OBSERVATIONS 
A. HIGH SENSITIVE C-REACTIVE PROTEINS: 
Risk stratification following acute myocardial infarction 
 According to the level of HS-CRP level just before the time of thrombolysis 
patients were classified into the following groups (TABLE 3), 
LOW RISK  <1 mg/dl 
INTERMEDIATE   
RISK 
1mg/dl- 3mg/dl
HIGH RISK >3 mg/dl 
MALE FEMALE MALE FEMALE MALE FEMALE 
20 3 19 6 43 9 
23 25 52 
TABLE 3 
In this series of 100 patients, 23 were in the low risk group, 25 were in 
intermediate risk group and 52 were in the high risk group (Graph 1, 2). 
. 
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GRAPH 1 
 
 
 
GRAPH 2 
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ANALYSIS OF WINDOW PERIOD (GRAPH 3, TABLE-4, 5, 6) 
 
LOW RISK GROUP: 
CHARACTERISTICS 
OF WINDOW 
PERIOD 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 1 HR 4 3 1 
1 HR- 3 HRS 4 3 1 
3 HRS- 6 HRS 9 8 1 
> 6 HRS- 12 HRS 6 6 0 
TABLE 4 
INTERMEDIATE RISK GROUP: 
CHARACTERISTICS 
OF WINDOW 
PERIOD 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 1 HR 0 0 0 
1 HR- 3 HRS 5 3 2 
3 HRS- 6 HRS 18 14 4 
> 6 HRS- 12 HRS 2 2 0 
TABLE 5 
HIGH RISK GROUP: 
CHARACTERISTICS 
OF WINDOW 
PERIOD 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 1 HR 0 0 0 
1 HR- 3 HRS 5 4 1 
3 HRS- 6 HRS 19 16 3 
> 6 HRS- 12 HRS 28 23 5 
TABLE 6 
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 GRAPH 3. WINDOW PERIOD DITRIBUTION  
 
 
GRAPH 4. EJECTION FRACTION DISTRIBUTION 
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ANALYSIS OF EJECTION FRACTION (GRAPH 4, TABLE-7, 8, 9) 
 
 LOW RISK GROUP: 
CHARACTERISTICS 
OF EJECTION 
FRACTION IN % 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 40 2 2 0 
40 – 60 13 12 1 
>60 8 6 2 
TABLE 7 
 
 
INTERMEDIATE RISK: 
CHARACTERISTICS 
OF EJECTION 
FRACTION IN % 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 40 2 1 1 
40 – 60 16 13 3 
>60 7 4 3 
TABLE 8 
 
 
HIGH RISK: 
CHARACTERISTICS 
OF EJECTION 
FRACTION IN % 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 40 13 10 3 
40 – 60 29 25 4 
>60 10 9 1 
TABLE 9 
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ANALYSIS OF REPERFUSION INJURY (GRAPH 5, TABLE-10, 11, 12) 
 
LOW RISK GROUP: 
CHARACTERISTICS 
OF REPERFUSION 
INJURY BY ST-
SEGMENT 
REGRESSION  IN % 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 50 1 1 0 
>50 22 20 2 
 
TABLE 10 
 
INTERMEDIATE RISK GROUP: 
CHARACTERISTICS 
OF REPERFUSION 
INJURY BY ST-
SEGMENT 
REGRESSION  IN % 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 50 2 2 0 
>50 23 18 5 
 
TABLE 11 
HIGH RISK: 
CHARACTERISTICS 
OF REPERFUSION 
INJURY BY ST-
SEGMENT 
REGRESSION  IN % 
TOTAL NO: 
OF PATIENTS MALE FEMALE 
< 50 22 15 7 
>50 30 28 2 
 
TABLE 12 
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GRAPH 5. REPERFUSION INJURY DISTRIBUTION 
 
 
 
CHARACTERISTICS LOW 
RISK 
INTERMEDIATE 
RISK 
HIGH 
RISK 
AGE 46.4 ± 7.86 51 ± 6.56 50.94 ± 8.63 
SEX 
MALE                                      20(82)                     19(82)                       43(82) 
FEMALE                                   3(18)                       6(18)                         9(18)  
RISK FACTORS (%)              
DIABETES                                5(29)                      9(29)                       15(29) 
HYPERTENSION                    7(49)                    16(49)                       26(49) 
SMOKING                              17(65)                    14(65)                        34(65) 
OC PILLS                                  1(1) 
HYPERHOMOCYSTEINEMIA  0(3)                  1(3)                           2(3) 
OBESITY                                      1(22)               7  (22)                       14(22) 
MEAN   HS-CRP 0.75 ± 
0.239 
2.02 ± 0.083 6.72 ± 1.76 
EJECTION 
FRACTION% 
57 ± 11 54.12 ± 10.76 50 ± 10.8 
TABLE 13. CHARACTERISTICS 
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SITE OF INFARCTION: 
 The most common site of infarction in the present study was 
Extensive Anterior Wall Myocardial Infarction. Second common site of 
infarction was in the inferior wall.  
Table 14: SITE OF INFARCTION IN BOTH GROUPS 
S.NO SITE OF INFARCTION 
NO.OF 
CASES 
1 ANTEROSEPTAL 24 
2 
ANTERO 
LATERAL 
4 
3 
EXTENSIVE 
ANTERIOR 
48 
4 INFERIOR WALL 21 
5 
POSTERIOR WALL 
MI 
3 
 TOTAL 100 
COMPLICATIONS: 
Unstable angina-3  
Non –ST Elevation Myocardial Infarction (NSTEMI)-1 
Death-3(Acute mitral regurgitation-1) 
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B. RISK FACTORS 
1) AGE & SEX (CHART 6): 
 Age and sex are definite risk factors. Total number of patients in this 
series was 100. The overall incidence is more in males compared to females. 
Table 15: AGE DISTRIBUTION OF PATIENTS 
S.No  AGE GROUP MALE FEMALE No. OF PATIENTS  PERCENTAGE
1  21‐30  1  1  2  2 
2  31‐40  14  3  17  17 
3  41‐50  26 5 31 31 
4  51‐60  29  6  35  35 
5  61‐70  12 3 15 15 
  TOTAL  82  18  100  100 
CHART 6: AGE AND SEX DISTRIBUTION 
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2) MENSTRUAL HISTORY: 
 In the present study 18 women were involved. The incidence of 
myocardial infarction was higher in the postmenopausal women (Table 16, 
Chart 7). 
TOTAL NO. OF 
PATIENTS 
PRE 
MENOPAUSAL 
PERI 
MENOPAUSAL 
POST 
MENOPAUSAL 
4 4 10 
PERCENTAGE% 22.22 22.22 55.55 
TABLE16 
 
 
CHART 7 
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3) ORAL CONTRACEPTIVE PILLS: 
 In the present study only 1 premenopausal woman was taking oral 
contraceptive pills for more than 3 months. 
4) CIGARETTE SMOKING (TABLE 17, CHART 8): 
 In the present study 65 (79.2%) males out of 82 males were cigarette 
smokers.  
SMOKERS  65 
NONSMOKERS  17 
TABLE 17 
 
CHART 8 
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5) ABDOMINAL OBESITY (TABLE 18, CHART- 9, 10): 
 In this study the waist circumference was recorded for all patients. Waist 
circumference more than >94cms for males and >80cm for females was taken 
as abdominal obesity. 
 In the present study 22 patients (22%) were obese, of which 14.64% 
were males and 55.55% were female patients. 
STATURE 
NON OBESE  OBESE MALE  OBESE FEMALE 
78  12  10 
TABLE 18 
Body mass index 
WHO CLASSIFICATION OF OBESITY 
TABLE 19 
CATEGORY BMI/QUETELET 
UNDER WEIGHT < 18.5 
HEALTHY WEIGHT 18.5- 24.9 
OVER WEIGHT 25 – 29.9 
MODERATELY OBESE 30 – 34.9 
SEVERLY OBESE 35 – 39.9 
MORBIDLY OBESE >40 
In this series 33(29 male and 4 female) patients were overweight, 8(6 male and 
2 female) were moderately obese, 1 male was severely obese and none were 
morbidly obese. 
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CHART 10 
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6) DIABETES MELLITUS: 
 In the present study, information regarding the prevalence of manifest 
diabetes was obtained from the interviews.  The patient was considered 
diabetic when there was a history of polyuria, polyphagia, and polydypsia, 
treatment with insulin or oral hypoglycemic agents. Increased blood sugar was 
also taken into consideration. ADA 2005 guidelines were followed. 
 In the present series 29 (29%) patients were diabetic. 23(79.3%) were 
males and 6(20.6%) were females among the diabetics (TABLE 20, CHART 
11, 12). 
STATUS PATIENTS 
NON DIABETES 71 
DIABETIC MALE 23 
DIABETIC FEMALE 6 
 
TABLE 20 
49 
71%
29%
PATIENTS
NON DIABETES
DIABETES 
  
CHART 11 
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CHART 12 
In the present study it is more common in males than in females. So 
diabetes had an important role both in males and females. 
 
50 
7) HYPERTENSION: 
 In the present series blood pressure was routinely checked for minimum 
three consecutive days. History of hypertension and the drugs they were taking 
were checked. Hypertension was noted in 49 (49%) patients, of which20 
(42.5%) were newly detected hypertensive’s (TABLE -21, 22, CHART- 13, 
14). Hypertension was noted in 39 male and 10 female. Of the newly detected 
75% were male and 25% were female. 
 
STATUS  PATIENTS 
NORMOTENSIVES  51 
HYPERTENSIVE MALE  39 
HYPERTENSIVE FEMALE  10 
TABLE 21 
 
STATUS  NEW HYPERTENSIVES 
MALE  15 
FEMALE  5 
TABLE 22 
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 CHART 13 
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8) SERUM LIPIDS (TABLE-23, 24, CHART -15, 16): 
In the present study cholesterol levels >200mg% were considered 
hypercholesterolemia, hypertriglyceridemia >160mg% and HDL < 40mg% 
were considered as risk factors. Hypercholesterolemia was seen in 44% 
patients. Of these 75% were male and 25% were female. Hypertriglyceridemia 
was seen in 33% patients. 
STATUS  DYSLIPIDEMIA IN % 
HYPERCHOLESTEROLEMIA  44 
HYPERTRIGLYCERIDEMIA  33 
LOW HDL  27 
TABLE 23 
Of these 75.7%were male and 24.24% were female. Low HDL was seen 
in 27% patients. Of these 22(81.4%) were male and 5(18.5%) were female. 
TABLE 24 
STATUS  TOTAL IN %  MALE  FEMALE 
HYPERTRIGLYCE
RIDEMIA 
33  25  8 
HYPERCHOLESTE
ROLEMIA 
44  33  11 
LOW HDL  27  22  5 
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 CHART 15 
 
CHART 16 
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DISCUSSION 
   DISCUSSION 
 Myocardial Infarction is more common in men than women. The risk 
factors, clinical features, course of the illness have extensively been studied. 
Due to the change in life style and cultural factors the incidence of myocardial 
infarction in females especially in premenopausal and perimenopausal age 
groups is on the rise.  
              In the present series 100 patients with Acute Myocardial Infarction 
with a window period of less than 12 hours who were admitted to intensive 
coronary care unit, CMC Hospital, Coimbatore -18, during the period between 
1st Jan 2006 to 30th Jun 2007 with typical history and ECG changes showing 
evidence of Myocardial Infarction were studied. 
C-reactive protein is a hepatically derived marker of low grade systemic 
inflammation that largely reflects circulating cytokine formation. It is produced 
from liver in response to cytokine stimulation (interleukin 1 and 6). According 
to AHA/CDC recommendations, High Sensitive -CRP levels are classified as: 
low High Sensitive -CRP < 1 mg/dl; average 1-3 mg/dl; and high High 
Sensitive -CRP >3 mg/dl.  
Higher High Sensitive - CRP levels in patients with AMI indicate an 
increased risk of subsequent coronary events because High Sensitive - CRP is 
associated with inflammation of coronary vessels. 
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It is reasonable to suggest that high High Sensitive ‐ CRP levels are 
associated with adverse outcome. Levels of hs-CRP are also elevated among 
those with acute coronary syndromes at high risk for recurrent events17,58-60 and 
among post-MI patients at high risk for recurrent instability.17,61 These effects 
are independent of other risk factors and appear to add to the predictive value 
of lipid screening in terms of risk prediction.17,58,62 However, there remains 
much confusion as to when it may be appropriate to measure hs-CRP levels, 
and what to do about them when they are found to be elevated. 
HS-CRP is a non-specific, highly sensitive marker of inflammation. One 
postulate regarding the unstable character of acute coronary syndrome is 
inflammation of the atherosclerotic lesion.6,63 Hence elevated plasma hs-CRP 
levels in patients with acute coronary syndrome on admission and its 
persistence after discharge may indicate a state of persistent inflammation and 
instability with poor short- and long-term prognosis.8-10,14 This was observed in 
various studies.15,64 The association of elevated High Sensitive -CRP and poor 
prognosis in patients with acute coronary syndrome is independent of other 
serum markers of myocardial cell injury and necrosis like cardiac Troponins and 
CK-MB.14 
Suleiman et al.65 showed that plasma High Sensitive -CRP level obtained 
within 12 to 24 hours of symptom onset is an independent marker of 30-day 
mortality and the development of heart failure in patients with AMI. High 
Sensitive - CRP levels may be related to inflammatory processes associated 
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with infarct expansion and post-infarction ventricular remodeling. Anzai et al.8 
showed that cardiac rupture, LV aneurysm formation, and one-year cardiac 
mortality were associated with an elevation of serum High Sensitive -CRP early 
after AMI. Berton et al.10 showed that first-day hs-CRP is a strong independent 
predictor of both heart failure progression and depressed LV ejection fraction in 
AMI. In contrast to above studies, Kimura et al.66 showed that elevated High 
Sensitive -CRP immediately after onset of AMI is associated with less 
myocardial damage and better LV function in reperfused anterior AMI. They 
have suggested that two mechanisms may account for the myocardial protective 
effect associated with the elevation of High Sensitive -CRP. First, silent 
myocardial ischemia, which is frequently associated with unstable angina, and 
in which High Sensitive -CRP levels may increase greatly, and may exert an 
ischemic preconditioning effect on the myocardium. Second, inflammation 
induces expression of angiogenic growth factors associated with reduced infarct 
size, and endogenous production of nitrous oxide protects the myocardium from 
ischemic reperfusion injury. 
In the present study of 100 Patients Of Acute Myocardial Infarction male 
(82%) had increased incidence than that of female (18%). Of the female, the 
post-menopausal age group (55.55%) had higher incidence than that of 
premenopausal (22.22%) and perimenopausal (22.22%) age groups. 
Maximum number was in the 51-60 year age group (35%). 41-50 year 
age group comes next (31%). The incidence was less below 30 years and above 
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60 years. The youngest patient was 26 year old female and the oldest patient 
was 70 years female. Among men youngest was 28 years and oldest was 69 
years. 
Oral contraceptive pills contributed to acute myocardial infarction in 1 
patient (1%). 
In the present study 65 (79.2%) males out of 82 males were cigarette 
smokers. There were no smokers in the female group.  
In the present study 22 patients (22%) were obese, of which 12(14.64%) 
were male and 10(55.55%) were female patients. So obesity is a major risk 
factor in female than in male, probably due to sedentary life style. 
In the present study, information regarding the prevalence of diabetes 
was obtained from the interviews.  The patient was considered diabetic when 
there was a history of polyuria, polyphagia and polydypsia, treatment with 
insulin or oral hypoglycemic agents. Increased blood sugar was also taken into 
consideration. ADA 2005 guidelines were followed. 
 In the present series, 29 (29%) patients were diabetic. 23(79.3%) were 
male and 6(20.6%) were female among the diabetics. So diabetes has an 
important role both in male and female. 
In the present series blood pressure was routinely checked for minimum 
three consecutive days and history of hypertension and the drugs they were 
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taking were checked. Hypertension was noted in 49 (49%) patients, of which 
20(42.5%) were newly detected hypertensives. Hypertension was noted in 39 
male and 10 female. Of the newly detected 15(75%) were male and 5(25%) 
were female. So hypertension is an important risk factor in male than in 
female. 
In the present study cholesterol levels >200mg% was considered, 
hypertriglyceridemia >160mg% and HDL < 40mg% were considered as risk 
factors and they were analysed in the study group. Hypercholesterolemia was 
seen in 44(44%) patients. Of these 75% were male and 25% female. 33(33%) 
were hypertriglyceridemia patients. Of these 25(75.7%) were male and 
8(24.24%) were female. Low HDL was seen in 27(27%) patients. Of these 
22(81.4%) were male and 5(18.5%) were female. Hypertriglyceridemia was 
seen in 33(33%). 
1) MULTIPLICITY OF RISK FACTORS: 
 Multiplicity of risk factors leading to 
Myocardial Infarction are common in men than women. 
           In the present study, risk stratification was done by the levels of HS-
CRP level just before the time of thrombolysis. Of these 23% belonged to the 
low risk group (<1 mg/dl), 25% belonged to the moderate risk group (1-3 
mg/dl) and 52% belonged to the high risk group (>3 mg/dl). 
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TABLE 24: RISK FACTORS IN BOTH GROUPS 
 
In the low risk group 86.9% were male and 13% were female .In 
moderate risk group 76% were male and 24% were female and in high risk 
group 82% were male and 18% were female. 
In the present study, in the low and moderate risk group thrombolysis 
was done at a lower window period i.e., it was < 6 hrs.In the high risk group 
thrombolysis was done between 6hrs-12 hrs. 
 
 
 
 
 
No. of Risk 
Factors 
TOTAL NO: OF 
PATIENTS 
MEN 
IN 
Percentage 
WOMEN 
IN 
Percentage 
NIL NIL NIL NIL 
1 16 12 4 
2 38 30 8 
3 27 23 4 
4 or More 19 17 2 
TOTAL 100 82 18 
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In the present study, the ejection fraction was higher in the low and 
moderate risk group than that of the high risk group. 
         In the present study, the reperfusion injury was found to be higher in the 
high risk group than that of the low and moderate risk group. 
   
PARTICULARS 
S Pandian et al 67 PRESENT 
LOW 
RISK 
HIGH 
RISK 
LOW 
RISK 
MODERAT
E RISK 
HIGH 
RISK 
MEAN AGE 50.2±7 50.1±8 46.4±7.86 51±6.56 
50.94±8.6
3 
SEX
 
MALE 36(90) 54(90) 20(82) 19(82) 43(82) 
FEMALE 4(10) 6(10) 3(18) 6(18) 9(18) 
MEAN CRP 
LEVEL 
1.26±0.9
1 
6.52±3.97 
0.75±0.23
9 
2.02±0.083 6.72±1.76 
EJECTION 
FRACTION 
56.9±7.7 46.7±11.9 57±11 54.12±10.76 50±10.8 
DIABETES 20(50) 30(50) 5(29) 9(29) 15(29) 
HYPERTENTIO
N 
14(35) 23(37) 7(49) 16(49) 26(49) 
SMOKING 18(45) 30(50) 17(65) 14(65) 34(65) 
61 
  
 
 
 
 
 
SUMMARY 
  SUMMARY 
1) In the estimation of High sensitive- C –reactive protein, the high risk 
group predominated at 52% with a mean of 6.72±1.76, intermediate risk -
25% with a mean of 2.02±0.083 and low risk - 23% with a mean of 
0.75±0.239. 
2) In all the groups male patients predominated. 
3) In the low and intermediate group the window period was predominantly 
in the range of 3- 6 hrs, in high risk group it was > 6 hrs. 
4)  The mean ejection fraction in the low risk was 57±11, intermediate risk 
was 54.12±10.76 and in high risk group it was 50±10.8. 
5) The reperfusion injury was only 4% in the low risk group, 8% in the 
intermediate risk and it was higher in the high risk group at 42%. 
6) The most common site of acute myocardial infarction was extensive 
anterior wall myocardial infarction followed by inferior wall myocardial 
infarction. 
7) Among women, 55.55% of post menopausal women had acute 
myocardial infarction. 
8) Oral contraceptive pill was a risk factor in 1 patient (5.5%). 
9) Smoking was one of the major risk factor in 79.2% of male patients. 
10)  Obesity was found to be a risk factor in 22% of patients.55.55%   
            among female were obese. 
11)  Diabetes was found in 29% of patients of which 79.3% were male. 
12)  Hypertension was seen in 49% patients. Of these 79.59% were male. 
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CONCLUSION 
 CONCLUSION 
In this Present study it is found that Ejection Fraction is lower in the high 
CRP group. Reperfusion injury is lower in the low and intermediate risk group 
according to the High Sensitive C –Reactive Protein assay. As echocardiogram 
was done only on day three after Acute myocardial infarction, a lot of stunned 
myocardium may be present, which is the limitation of this study. 
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PROFORMA 
         RECORD 
 
NAME:                AGE:      SEX: M/F   
I.P.NO:        DOA:        DOD: 
DIAGNOSIS: 
WINDOW PERIOD: 
   
C/O:        CHEST PAIN‐TYPE, RADIATION 
  SWEATING 
  PALPITATION 
  SYNCOPE 
  DYSPNOEA 
  PND, ORTHOPNOEA 
  GIDDINESS 
  NAUSEA & VOMITING 
 
 
 
HOPI: 
 
 
  74 
RISK FACTORS: DM/HT/SMOKING/COPD 
DIET:  VEG/NONVEG/MIXED 
FAMILY HISTORY: 
IHD/OBESITY/DIABETES/HYPERTENSION/HYPERLIPIDEMIA                     
TREATMENT HISTORY:    DRUG INTAKE 
MARITAL HISTORY 
GENERAL EXAMINATION:  
 OBESITY 
 DYSPNOEA 
 CYANOSIS 
 CLUBBING 
 PITTING PEDAL EDEMA 
 XANTHALESMA 
 TENDON XANTHOMAS 
 ARCUS SENILIS 
 PULSE 
 BLOOD PRESSURE 
 WAIST CIRCUMFERENCE 
 
BP: 
HEIGHT:      WEIGHT:      BMI:   
WAIST:HIP RATIO:       
ANKLE‐BRACHIAL INDEX: 
CARDIOVASCULAR SYSTEM 
 
  APICAL IMPULSE    S1    S2    S3 
 
  PERICARDIAL RUB   PERIPHERAL VASCULAR SYSTEM 
75 
 RESPIRATORY SYSYEM 
 
 
ABDOMEN 
 
 
CENTRAL NERVOUS SYSTEM 
INVESTIGATION 
LIPID PROFILE:‐ 
TOTAL CHOLESTEROL:    mg% 
TGL:    mg%  HDL:    mg%  LDL:  mg% 
WBC COUNT: 
HS‐CRP:    mg/L    URIC ACID:    mg% 
ELECTROCARDIOGRAM: 
BEFORE THROMBOLYSIS: 
 
 
AFTER THROMBOLYSIS: 
 
 
ECHOCARDIOGRAM: 
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 CHEST X‐RAY 
URINE ROUTINE 
BLOOD SUGAR  
BLOOD UREA 
SERUM CREATININE 
 
 
RISK: 
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FOLLOW UP SHEET 
COIMBATORE MEDICAL COLLEGE  
&  
HOSPITAL 
DEPARTMENT OF MEDICINE 
  NAME:   
AGE:      SEX:M/F    I.P.NO: 
DOA: 
DOD: 
DIAGNOSIS: 
 
WINDOW PERIOD: 
HS‐CRP:          EF: 
RISK: 
COMPLICATIONS‐ 
 
            SYMPTOMS     SIGNS    DIAGNOSIS      THERAPY 
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